These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 21308251)

  • 21. Dopamine neuronal tracts in schizophrenia: their pharmacology and in vivo glucose metabolism.
    Tamminga CA; Burrows GH; Chase TN; Alphs LD; Thaker GK
    Ann N Y Acad Sci; 1988; 537():443-50. PubMed ID: 2904785
    [No Abstract]   [Full Text] [Related]  

  • 22. A dopaminergic deficit hypothesis of schizophrenia: the path to discovery.
    Carlsson A; Carlsson ML
    Dialogues Clin Neurosci; 2006; 8(1):137-42. PubMed ID: 16640125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serotonin-dopamine antagonists and treatment of negative symptoms.
    Carpenter WT
    J Clin Psychopharmacol; 1995 Feb; 15(1 Suppl 1):30S-35S. PubMed ID: 7730498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Schizophrenia: from dopamine to glutamate and back.
    Carlsson ML; Carlsson A; Nilsson M
    Curr Med Chem; 2004 Feb; 11(3):267-77. PubMed ID: 14965231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Three cases of schizophrenia showing improvement after switching to blonanserin.
    Kurotaki N; Nobata H; Nonaka S; Nishihara K; Ozawa H
    Psychiatry Clin Neurosci; 2011 Jun; 65(4):396-7. PubMed ID: 21682816
    [No Abstract]   [Full Text] [Related]  

  • 26. Dopamine and schizophrenia--proof at last?
    Harrison PJ
    Lancet; 2000 Sep; 356(9234):958-9. PubMed ID: 11041394
    [No Abstract]   [Full Text] [Related]  

  • 27. Dopamine and its relation to schizophrenia and antipsychotic drugs.
    Tarnoff GM
    Bull Menninger Clin; 1978 Jul; 42(4):321-38. PubMed ID: 29683
    [No Abstract]   [Full Text] [Related]  

  • 28. Neuroendocrine serotonergic and dopaminergic responsivity in male schizophrenic patients during treatment with neuroleptics and after switch to risperidone.
    Markianos M; Hatzimanolis J; Lykouras L
    Psychopharmacology (Berl); 2001 Aug; 157(1):55-9. PubMed ID: 11512043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alterations of dopamine and serotonin transmission in schizophrenia.
    Remington G
    Prog Brain Res; 2008; 172():117-40. PubMed ID: 18772030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathophysiology of schizophrenia and the role of newer antipsychotics.
    Risch SC
    Pharmacotherapy; 1996; 16(1 Pt 2):11-4. PubMed ID: 8778681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Classics in Chemical Neuroscience: Chlorpromazine.
    Boyd-Kimball D; Gonczy K; Lewis B; Mason T; Siliko N; Wolfe J
    ACS Chem Neurosci; 2019 Jan; 10(1):79-88. PubMed ID: 29929365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigational dopamine antagonists for the treatment of schizophrenia.
    Wang SM; Han C; Lee SJ; Jun TY; Patkar AA; Masand PS; Pae CU
    Expert Opin Investig Drugs; 2017 Jun; 26(6):687-698. PubMed ID: 28443355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopaminergic modulation of the P50 auditory-evoked potential in a computer model of the CA3 region of the hippocampus: its relationship to sensory gating in schizophrenia.
    Moxon KA; Gerhardt GA; Adler LE
    Biol Cybern; 2003 Apr; 88(4):265-75. PubMed ID: 12690485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Current concepts of the effects of neuroleptics].
    Kostowski W; Płaźnik A
    Psychiatr Pol; 1990; 24(5):28-37. PubMed ID: 1983397
    [No Abstract]   [Full Text] [Related]  

  • 35. [3 years of risperidone: from innovation to example].
    Nervenarzt; 1997 Apr; 68(4 Suppl Von Der In):1-4. PubMed ID: 9442496
    [No Abstract]   [Full Text] [Related]  

  • 36. Flupentixol.
    Nurs Times; 2006 Jul 4-10; 102(27):31. PubMed ID: 16850705
    [No Abstract]   [Full Text] [Related]  

  • 37. Extrastriatal and striatal D(2) dopamine receptor blockade with haloperidol or new antipsychotic drugs in patients with schizophrenia.
    Xiberas X; Martinot JL; Mallet L; Artiges E; Loc'H C; Mazière B; Paillère-Martinot ML
    Br J Psychiatry; 2001 Dec; 179():503-8. PubMed ID: 11731352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuropharmacology of second-generation antipsychotic drugs: a validity of the serotonin-dopamine hypothesis.
    Kuroki T; Nagao N; Nakahara T
    Prog Brain Res; 2008; 172():199-212. PubMed ID: 18772034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Schizophrenia: a systematic review of the disease state, current therapeutics and their molecular mechanisms of action.
    Shin JK; Malone DT; Crosby IT; Capuano B
    Curr Med Chem; 2011; 18(9):1380-404. PubMed ID: 21366526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopamine D4 receptors: curiouser and curiouser.
    Strange PG
    Trends Pharmacol Sci; 1994 Sep; 15(9):317-9. PubMed ID: 7992381
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.